Dergiler / Turkish Journal of Internal Medicine / 2022 / Supplement 1

Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,

Sayfa
158–159
Yayın Tarihi
2022-04-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Posttransplant lymphoproliferative diseases are complications that develop after solid organ transplantation.
📊
Temel Bulgular & Veri:Primary EBV infection is one of the most important risk factors.
💡
Sonuç & Katkı:After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Post-transplant · Lymphoproliferative Disorder · Kidney Transplantation

Abstract

Posttransplant lymphoproliferative diseases are complications that develop after solid organ transplantation. Primary EBV infection is one of the most important risk factors. After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.

🔖

Bu Makaleye Atıf Yap

CANDAR, Ö., TURNA, T. Z. (2022). Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,. Turkish Journal of Internal Medicine, Supplement 1, 158–159. https://ajindex.com/articles/809006

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Maksten EF, Vase MØ, Kampmann J, d’Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study. Transpl Int. 2016 Apr;29(4):483- 93. doi: 10.1111/tri.12744. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int. 2007 Mar;20(3):207-18. doi: 10.1111/j.1432- 2277.2006.00416.x. Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): Risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
  2. Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013 Feb;13 Suppl 3:41-54; quiz 54. doi: 10.1111/ajt.12004.
  3. Hutton B, Joseph L, Yazdi F, Tetzlaff J, Hersi M, Kokolo M, Fergusson N, Bennett A, Buenaventura C, Fergusson D, Tricco A, Strauss S, Moher D, Knoll G. Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: protocol for a network meta- analysis of randomized and observational studies. Syst Rev. 2014 Feb 22;3:16. doi: 10.1186/2046-4053-3-16.